Compound ID | 885
Class: Quinoline-indole
Spectrum of activity: | Gram-negative |
Details of activity: | Lysis followed bacteria death, thought to be related to membrane damage |
Institute where first reported: | Sepracor (Sunovion Pharmaceuticals, Inc) |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://journals.asm.org/doi/full/10.1128/aac.47.2.458-466.2003?cited-by=yes&legid=aac%3B47%2F2%2F458 |